This article is more than 5 years old. Information may no longer be current.

Dana-Farber surgical oncology chief to assume ASCO presidency in 2018

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Monica M. Bertagnolli, MD, has been elected president of ASCO for the 2018-2019 term.

Monica M. Bertagnolli

Bertagnolli — chief of the division of surgical oncology at Dana-Farber/Brigham and Women’s Cancer Center, as well as associate surgeon at Brigham and Women’s Hospital and Dana-Farber Cancer Institute — will assume the presidency in June 2018. She will begin a 1-year term as president-elect this summer.

Bertagnolli, a member of ASCO since 1995, has served on the society’s board of directors and its cancer prevention committee.

“Serving as ASCO president is a tremendous honor for anyone in the field of oncology,” Bertagnolli said in a press release. “Much more importantly, it is an opportunity for me to make a meaningful difference by providing a strong voice in the health care community for those whom I consider to be my particular constituency: clinical and translational researchers, community and academic oncologists participating in clinical research, and surgical oncologists.”